Zhejiang Kanova Biopharmaceutical Co., LTD
6 clinical trials · Sponsor
◉ Watch Zhejiang Kanova Biopharmaceutical Co., LTD
| Record | Firm | Date |
|---|---|---|
| Bridging Study of XKH001 in Healthy Adult Caucasian Participants (NCT07757659) | Zhejiang Kanova Biopharmaceutical Co., LTD | 2026-08-01 |
| Phase II Clinical Study to Evaluate the Efficacy and Safety of XKH001 Injection (NCT07519499) | Zhejiang Kanova Biopharmaceutical Co., LTD | 2026-04-01 |
| Evaluate the Efficacy and Safety of XKH001 Injection in Patients With Moderate-to-Severe Atopic Dermatitis (NCT07054736) | Zhejiang Kanova Biopharmaceutical Co., LTD | 2025-08-31 |
| A Single-Arm Phase Ic Clinical Study of XKH001 Injection in Patients With Allergic Asthma After Multiple Doses (NCT07070297) | Zhejiang Kanova Biopharmaceutical Co., LTD | 2023-12-26 |
| Phase I of XKH002 Injection in Patients (NCT06196762) | Zhejiang Kanova Biopharmaceutical Co., LTD | 2023-11-27 |
| Recombinant Anti-human IL-17A/F Humanized Monoclonal Antibody Injection in the Treatment of Moderate-to-Severe Active AS (NCT07498634) | Zhejiang Kanova Biopharmaceutical Co., LTD | 2023-09-21 |
Track Zhejiang Kanova Biopharmaceutical Co., LTD automatically
Every clearance here is in the API, with alerts when new ones post.